Applications published 12 September 2007
Compsns comprising polymeric emulsifiers and methods using same
Johnson & Johnson Consumer Companies 1830805*
Sustained release formulation comprising bisphosphonate
Novartis; Novartis-Pharma 1830806*
A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
Zhang, Jin Jun 1830807*
Plastic bottle for oxaliplatin solution
Hexal 1830808*
Injectable non-aqueous suspension
Alza Corp 1830809*
Spray-dried compsn containing collectin family proteins or variants thereof and process for preparing the same
Dobeel 1830810*
Method for preparing a solid pharmaceutical compsn with prolonged and controlled release by high pressure treatment
Ceva Sante Animale 1830811*
Anti-viral uses of metal nanomaterial compsns
Nanotechnologies; Board of Regents, The University of Texas System 1830812*
Lipid particles comprising bioactive agents, methods of preparing and uses thereof
Transave 1830813*
Taste masking system for non-plasticising drugs
CIMA Labs 1830814*
Enteric coated azithromycin multiparticulates
Pfizer Products 1830815*
Solid dosage form comprising proton pump inhibitor and suspension made thereof
AstraZeneca 1830816*
Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
Pierre Fabre Medicament 1830817*
Process for the manufacture of sterile suspensions or lyophilisates of low-stable basic peptide complexes, pharmaceutical formulations comprising these complexes and their use as medicament
Aeterna Zentaris 1830818*
Stable pharmaceutical compsn comprising amoxicillin and clavulanic acid
LEK Pharmaceuticals 1830819*
Controlled release for oral administration of medicine for diabetes and method for the preparation
Hanmi Pharm 1830820*
Two-phase toothpaste compsn
Colgate-Palmolive 1830821*
Stable pharmaceutical compsn comprising an active substance in the form of solid solution
LEK Pharmaceuticals 1830822*
Stable oral benzimidazole compsns and process of preparation thereof
Ranbaxy Laboratories 1830823*
Nanoparticle compsns and methods for synthesis thereof
Iceutica 1830824*
Use of a compound capable of increasing glutathione level in melanocytes for treating canities
L'Oreal 1830825*
Use of a compound that activates a vitamin D receptor for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals
Abbott Laboratories 1830826*
Perfluorocarbon liquids as carcinogen
Matsumoto, Kaizen Robert 1830827*
Use of methyl pyruvate to increase cellular energy production downstream of glycolysis
Antosh & Meduri Holding Corp 1830828*
Sphingolipids in treatment and prevention of steatosis and of steatosis or of hepatotoxicity and its sequelae
Nederlandse Organisatie voor toegepastnatuurwetenschappelijk onderzoel TNO 1830829*
Omega-3 fatty acids and dyslipidemic agent for lipid therapy
Reliant Pharmaceuticals 1830830*
Pharmaceutical formulations of gallium salts
Emisphere Technologies 1830831*
Zinc-containing treatments for hyperphosphataemia
Genzyme Corp 1830832*
Combination of a glycine transporter (GLYT1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof
Janssen Pharmaceutica 1830833*
Compsn for promoting production of hylauronic acid containing kaempferol and quercetin
Amorepacific Corp 1830834*
Use of a vanilloid receptor agonist together with a glycosaminoglycan or proteoglycan for producing an agent for treating articular pains and method for applying said agent
Mestex 1830835*
Mixture of vanolloid receptor agonist and a substance inhibiting nerve regeneration, use thereof for producing a painkiller, and method for applying said painkiller
Mestex 1830836*
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
Xenon Pharmaceuticals 1830837*
Compsns and methods for treating neoplastic diseases
Dana-Farber Cancer Institute 1830838*
System and method for power management in mobile units
Symbol Technologies 1830839*
Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
Eli Lilly 1830840*
Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
Eli Lilly 1830841*
Medicaments for the treatment or prevention of fibrotic diseases
Boehringer Ingelheim International 1830842*
Indolinone derivatives for the treatment or prevention of fibrotic diseases
Boehringer Ingelheim International; Boehringer Ingelheim Pharma 1830843*
Antidepressant medicament comprising idazoxan and a selective serotonin reuptake inhibitor
Alpha 2 Pharmaceutical 1830844*
Improved dosage regimen of temozolomide for treating cancer based on the patient's MGMT level
Schering Corp 1830845*
Thiazolium compounds and uses thereof
Mycosal 1830846*
Treatment for cancer
Newsmouth Innovations 1830847*
Use of thiazolidinone derivatives as antiangiogenic agents
Cell Therapeutics 1830848*
Fast release dosage forms for antibiotics
Gruenenthal 1830849*
Quinoline derivatives for the treatment of latent tuberculosis
Janssen Pharmaceutica 1830850*
Rapid disintegrating taste masked compsns and a process for its preparations
Thenis Laboratories Private 1830851*
Compounds with mixed PDE-inhibitory and beta-adrenergic antagonist of partial agonist activity for treatment of heart failure
Artesian Therapeutics 1830852*
Aminopyrazine analogues for treating glaucoma and other RHO kinase-mediated diseases
Alcon 1830853*
Arylpiperazine derivatives and use thereof as 5-HT1A receptor ligands
Schwarz Pharma 1830854*
Solid, orally administerable pharmaceutical administration forms containing rivaroxaban having modified release
Bayer Healthcare 1830855*
Preventing pathological increases in the rate of nerve cell suicide in immature nervous systems
Olney, John 1830856*
Treatment of graft-versus-host disease and leukaemia with becolmethasone diporpionate and prednisone
Dor Biopharma 1830857*
3,6-bicyclolide
Enanta Pharmaceuticals 1830858*
Methods and compsns for treatment of viral infections
Cavit Sciences 1830859*
Stable non-dihydrate azithromycin oral suspensions
Pfizer Products 1830860*
Antiviral and immunostimulating marine fish oil compsn
Sinnex Mueszaki Fejlesztoe S Tanacsado 1830861*
Adipose-derived stem cells for tissue regeneration and wound healing
PrimeGen Biotech 1830862*
Protein formulation
Straumann Holding 1830863*
E1-minus adenoviruses and use thereof
Holm, Per Sonne 1830864*
Topical treatment compsns
Gallmann, Kuki 1830865*
Methods and compsns concerning siRNAs as mediators of RNA interference
Ambion 1830866*
Irreversibly-inactivated pepsinogen fragment and pharmaceutical compsns comprising this fragment for detecting, preventing, and treating HIV
Zhabilov, Harry 1830867*
DAP-10 and uses thereof
Schering 1830868*
Method of treatment or prophylaxis
The University of Queensland 1830869*
Compounds for flaviviridae treatment
Novartis 1830870*
Compsns for HCV treatment
Novartis 1830871*
Fusion proteins
Health Protection Agency, Porton Down 1830872*
Glyponectin (glycosylated adiponectin) for the treatment of diseases and conditions
Protemix Corp 1830873*
Compsns for enhancing keratinocyte migration and epidermal repair via a receptor containing OSMRbeta as a subunit, and applications thereof
Universite d'Angers; Universite de Poitiers; Bioalternatives SAS 1830874*
IL-15 antigen arrays and uses thereof
Cytos Biotechnology 1830875*
Treatment for cutaneous metastases
3m Innovative Properties 1830876*
Recombinant BCG strains with attenuated immunosuppressive properties
Aeras Global TB Vaccine Foundation 1830877*
Compsns comprising OPA protein epitopes
Isis Innovation 1830878*
MRI guided photodynamic therapy for cancer
University of Utah Research Foundation 1830879*
Multi-route administration of immune response modifier compounds
Coley Pharmaceutical 1830880*
Combining therapies targeting multiple toll-like receptors and use thereof
Novimmune 1830881*
Process for the preparation of a boron-substitute porphyrin
Psimei Pharmaceuticals 1830882*